Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CRP

  • You have access
    Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
    MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA
    Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
  • You have access
    Laboratory Parameters Associated With Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer
    MARTIN SVATON, MARIE DROSSLEROVA, ONDREJ FISCHER, MILOSLAV MAREL, MICHAL HRNCIARIK, ONDREJ VENCLICEK, PETR ZUNA, MICHAL SVOBODA, JIRI BLAZEK, MONIKA BRATOVA, ANDREA MULLEROVA, BOHUSLAVA VANKOVA and DANIEL KREJCI
    Anticancer Research March 2022, 42 (3) 1563-1569; DOI: https://doi.org/10.21873/anticanres.15630
  • You have access
    Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion
    STEFANO M.M. BASSO, ALESSANDRO DEL CONTE, UMBERTO ZUCCON, SANDRO C. SULFARO, GIOVANNI FANTI, FEDERICA MAFFEIS, PAOLO UBIALI, MARIO ERMANI and FRANCO LUMACHI
    Anticancer Research October 2020, 40 (10) 5877-5881; DOI: https://doi.org/10.21873/anticanres.14607
  • You have access
    Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma
    MIO YANAGISAWA, ALICIA A. GINGRICH, SEAN JUDGE, CHIN-SHANG LI, NANA WANG, STEVEN W. THORPE, AMANDA R. KIRANE, RICHARD J. BOLD, ARTA M. MONJAZEB and ROBERT J. CANTER
    Anticancer Research March 2018, 38 (3) 1491-1497;
  • You have access
    Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer
    AMANIKA KUMAR, MICHELLE L. TORRES, WILLIAM A. CLIBY, KIMBERLY R. KALLI, GIORGIO BOGANI, GIOVANNI ALETTI, CAROLINE C. NITSCHMANN, FRANCESCO MULTINU, AMY L. WEAVER, MATTHEW S. BLOCK and ANDREA MARIANI
    Anticancer Research July 2017, 37 (7) 3673-3677;
  • You have access
    Preoperative Serum C-Reactive Protein and its Prognostic Significance in Patients with Stage III-IV Colorectal Cancer
    FRANCO LUMACHI, STEFANO M.M. BASSO, DAVIDE A. SANTEUFEMIA, MARIO ERMANI, GIOVANNI LO RE and GIORDANO B. CHIARA
    Anticancer Research December 2014, 34 (12) 7263-7266;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire